Essex Investment Management CO LLC Amgen Inc Transaction History

Essex Investment Management CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $146,932 - $182,421	-672 Reduced 15.5%	3,664 $984,000
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $70,446 - $85,862	-312 Reduced 6.71%	4,336 $1.05 Million
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $60,005 - $76,244	-262 Reduced 5.34%	4,648 $1.22 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $47,526 - $52,888	-206 Reduced 4.03%	4,910 $1.2 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $1.12 Million - $1.24 Million	5,116 New	5,116 $1.24 Million
Q1 2020 May 04, 2020	SELL	$182.24 - $241.7 $18,224 - $24,170	-100 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $18,087 - $20,388	-100 Reduced 50.0%	100 $19,000
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $35,680 - $41,650	200 New	200 $39,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.